The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Hepatitis C
Open accessAbstract
Hepatitis C virus (HCV) infection is a major global health problem that continues to grow with an estimated 170 million people infected. The consequences of chronic infection can include cirrhosis, end-stage liver disease and hepatocellular carcinoma. Due to shared routes of transmission, coinfection with HIV is a significant problem and individuals infected with both viruses have poorer outcomes. There is no effective vaccine though HCVis a potentially curable persistent viral infection. For many years, the standard of care has been subcutaneous interferon-alpha and oral ribavirin for between 24 and 72 weeks of treatment. This treatment results in a sustained virological response in only about 50% of individuals and is complicated by significant adverse events. In recent years, advances in HCV cell culture has allowed a greater understanding of HCV virology and this has paved the way for the development of many new directly acting antiviral drugs that target key components of virus replication such as protease and polymerase inhibitors. We are now at a point of improved and simplified treatments for HCV that may be administered as oral regimens of short duration and with far greater tolerability than regimens of old. The remaining hurdles may be access to appropriate care and cost of treatment as the epidemic continues to grow.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Terrault, N. A., Dodge, J. L., Murphy, E. L., Tavis, J. E., Kiss, A., Levin, T. R., Gish, R. G., Busch, M. P., Reingold, A. L., & Alter, M. J. (2013) · Hepatology · doi:10.1002/hep.26164 · Cited by 263
Evolving Epidemiology of Hepatitis C Virus in the United States
Klevens, R. M., Hu, D. J., Jiles, R., & Holmberg, S. D. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis393 · Cited by 214
Cited by
Regulation of microRNA function in animals
Gebert, L. F. R., & MacRae, I. J. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0045-7 · Cited by 2,284
Muchtar, E., Magen, H., & Gertz, M. A. (2017) · Blood · doi:10.1182/blood-2016-09-719773 · Cited by 190
Bering, T., Diniz, K. G. D., Coelho, M. P. P., Vieira, D. A., Soares, M. M. S., Kakehasi, A. M., Correia, M. I. T. D., Teixeira, R., Queiroz, D. M. M., Rocha, G. A., et al. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12269 · Cited by 73
Saha, B., Kodys, K., & Szabo, G. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.12.005 · Cited by 65
HCV-Specific T Cell Responses During and After Chronic HCV Infection
Luxenburger, H., Neumann-Haefelin, C., Thimme, R., & Boettler, T. (2018) · Viruses · doi:10.3390/v10110645 · Cited by 64
Metadata
- Authors
- Webster, D. P., Klenerman, P., & Dusheiko, G. M.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 385
- Issue
- 9973
- Pages
- 1124-1135
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2394500959
- Cited by
- 439
- References
- 3
- FWCI
- 45.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatitis C. https://app.cochat.ai/papers/10.1016/s0140-6736(14)62401-6
- The paper
- Webster, D. P., Klenerman, P., & Dusheiko, G. M. (2015). Hepatitis C. The Lancet. https://doi.org/10.1016/s0140-6736(14)62401-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.